China Pharma HoldingsCPHI

13F holders, Q1 2026 (March 31)
6holders +1
2new positions
1sold out
2famous investors
$0.61avg. 13F price*

At the end of Q1 2026, 6 institutions reported holding China Pharma Holdings Inc. (CPHI) in their 13F filings, up 1 from Q4 2025. 2 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($8K), Renaissance Technologies ($7K) and Citigroup Inc. ($608). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
China Pharma Holdings Inc.
CUSIP
16941T401
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q2 2025: 5Q2 2025Q3 2025: 5Q3 2025Q4 2025: 5Q4 2025Q1 2026: 6Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions2$8K
Exits1$21K

All 13F filers, Q4 2025 → Q1 2026: 14,020 shares bought and 17,547 shares sold, net −3,527 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

Citadel Advisors 0.00% New 12,924 $8K
Renaissance Technologies 0.00% Add +0.9% 11,418 $7K
Citigroup Inc. 0.00% New 996 $608
UBS Group AG 0.00% Reduce -24.2% 389 $237
EFG International AG 0.00% No change 40 $24
Danske Bank A/S 0.00% No change 1 $1

"% of holder's portfolio" is CPHI's weight in each manager's 13F, not the share of China Pharma Holdings Inc. the manager owns.